American Electric Power Company Inc vs Novo Nordisk A/S — how do they compare? American Electric Power Company Inc trades at $123.8 (market cap $67.28B), while Novo Nordisk A/S trades at $46.04 (market cap $207.85B). The key difference: Novo Nordisk A/S is far larger — about 3.1× American Electric Power Company Inc's market cap, and Novo Nordisk A/S pays the higher dividend (3.81%). Which is the better fit depends on your goals.
| AEP | NVO | |
|---|---|---|
Market Cap | $67.28B | $207.85B |
Sector | Utilities | Health |
52-Week High | $138.69 | $63.98 |
52-Week Low | $106.44 | $35.29 |
Enterprise Value | $120.17B | $222.55B |
Dividend Yield | 3.07% | 3.81% |
Trailing returns across standard periods
American Electric Power is one of the largest regulated utilities in the United States, providing electricity generation, transmission, and distribution to more than 5 million customers in 11 states. About 43% of AEP's of capacity is coal, with the remainder from a mix of natural gas (27%), renewable energy and hydro (19%), nuclear (7%), and demand response (4%). Vertically integrated utilities, transmission and distribution, and generation and marketing support earnings.
Read more on AEP →With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →